EP PerMed organised a roundtable discussion on ‘De-risking Innovation in Personalised Medicine’ on 27 May 2024 in Brussels. The event accompanied the Belgian Presidency of the EU and aimed to shape the future of healthcare in the Benelux region and beyond.
Report
Over the next decade, Personalised Medicine (PM) is expected to make a significant contribution to healthcare, for example by tailoring the right preventive or therapeutic strategy to the right person at the right time. It will also create new opportunities for innovation and economic growth. As we embark on this journey, our goal is clear: to increase the visibility and awareness of PM, to assess readiness for implementation, and to identify concrete ways to accelerate its development. Together, let’s seize this opportunity to shape the future of healthcare.
Our Roundtable on Personalised Medicine promised to spark important conversations, drive innovation and foster collaboration towards a healthcare landscape that is personalised. We invited professionals who are passionate about advancing healthcare to register now and be part of this transformative journey.
The event was organised by EP PerMed Partner EIT Health and was open to industry leaders, clinicians, healthcare providers, patient advocates, policy makers, government agencies, data specialists, researchers and academics.
Agenda
15:30 – 16:00
Registration and coffee
16:00 – 16:05
Welcome and introduction
16:05 – 16:25
Keynote I
Jérôme Van Biervliet, Managing Director VIB
16:25 – 17:25
Roundtable discussion – Talen & Skills
Panellists:
- Sofie Bekaert, King Baudouin Foundation
- Montse Daban, Biocat
- Elfride De Baere, Ghent University Hospital
- Marc Dechamps, Bioxodes SA / Solvay BSEM
- Isabelle Francois, Medvia
- Jens Habermann, BBMRI-ERIC
- Pieter Jacobs, Legend Biotech
- Marc Van Den Bulcke, Sciensano
17:25 – 17:55
Break
17:55 – 18:15
Keynote II
Ejner Moltzen, ICPerMed Chair
18:15 – 19:15
Roundtable discussion – Supporting infrastructures
- Sofie Bekaert, King Baudouin Foundation
- Montse Daban, Biocat
- Elfride De Baere, Ghent University Hospital
- Marc Dechamps, Bioxodes SA / Solvay BSEM
- Isabelle Francois, Medvia
- Jens Habermann, BBMRI-ERIC
- Pieter Jacobs, Legend Biotech
- Marc Van Den Bulcke, Sciensano
19:15 – 19:25
Conclusions and closing
19:25 – 20:30
Networking drinks
Event Venue
EIT House, Guimardstraat 7, 1040 Brussel, Belgium